Natural Cycles Secures $55 Million Series C Funding to Accelerate Growth Ahead of Possible IPO
Summary
Natural Cycles, a womens health company known for developing the worlds first birth control app, has announced the successful closure of its $55 million Series C financing round. The companys app is cleared by regulatory authorities in the United States (FDA), Europe (T\xdcV S\xdcD), Canada (Health Canada), Australia (TGA), Singapore (HSA), and South Korea (MFDS) as a digital birth control method.The new funds will be directed towards accelerating the companys commercial efforts, developing new products, and automating healthcare reimbursement processes. We look forward to leveraging their expertise to fulfill Natural Cycles mission of making hormone-free birth control more accessible and combining technology and science to fill the gaps in underserved areas of womens health.Scherwitzl also told Axios that Natural Cycles sought a Series C to bring in growth equity investors with IPO experience, which points to a possible exit scenario, and that the new funds put the company in a strong position to make acquisitions if theres technology we like that complements our roadmap.Natural Cycles has recently expanded its offerings with the launch of NC\xb0 Postpartum, a new feature within the app designed to support new mothers in their physical and mental recovery after childbirth. The visionary Natural Cycles team has built an exceptional company delivering profitable growth supported by unique clinical and regulatory business moats. We are delighted to partner with Elina, Raoul and their team to offer women an alternative to traditional approaches without the side effects and compromises.
Funding
Review available funding amount, funding date, investors, and linked company information related to Natural Cycles Secures $55 Million Series C Funding to Accelerate Growth Ahead of Possible IPO in the interactive ISVWorld profile.